tiprankstipranks
Shanghai Fosun Pharma Announces Capital Reduction
Company Announcements

Shanghai Fosun Pharma Announces Capital Reduction

Shanghai Fosun Pharmaceutical (Group) Co (HK:2196) has released an update.

Don't Miss Our Christmas Offers:

Shanghai Fosun Pharmaceutical (Group) Co., Ltd. has announced a reduction in both its issued share capital and registered capital following the cancellation of 1,072,246 Restricted Shares. The company’s total issued share capital has decreased, and amendments to the Articles of Association have been made to reflect the updated capital structure. These changes are part of the resolutions passed by shareholders and are in compliance with relevant PRC laws and regulations.

For further insights into HK:2196 stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks HongKong Auto-Generated NewsdeskShanghai Fosun Pharmaceutical Advances Henlius Merger Plans
TipRanks HongKong Auto-Generated NewsdeskShanghai Fosun Pharma Moves Hong Kong Office
TipRanks HongKong Auto-Generated NewsdeskShanghai Fosun Pharmaceutical Moves Forward with Henlius Merger
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App